Contents

Current Medicinal Chemistry - Central Nervous System Agents, Volume 3 - Number 1

Preface

, 3(1): i

Gregory S. Hamilton


DOI: 10.2174/1568015033357814




Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse

, 3(1): 1 - 26

Sergi Ferre, Francisco Ciruela, Amina S. Woods, Meritxell Canals, Javier Burgueno, Daniel Marcellino, Marzena Karcz-Kubicha, Bruce T. Hope, Marisela Morales, Patrizia Popoli, Steven R. Goldberg, Kjell Fuxe, Carme Lluis, Rafael Franco and Luigi Agnati


DOI: 10.2174/1568015033357779




Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists

, 3(1): 27 - 36

Henri Mattes and Hans-Juergen Pfannkuche


DOI: 10.2174/1568015033357724




Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: 5-HT4 Receptor Antagonists

, 3(1): 37 - 42

Henri Mattes and Hans-Juergen Pfannkuche


DOI: 10.2174/1568015033357742




New Approaches in the Treatment of Overactive Bladder: Targeting Adrenergic Receptors and Neurokinin Receptors

, 3(1): 43 - 47

O. Ishizuka


DOI: 10.2174/1568015033357661




The Therapeutic Potential of Amphetamines in Post-stroke Recovery

, 3(1): 49 - 55

Anwar Khokar, Jawad F. Kirmani, Andrew R. Xavier and Adnan I. Qureshi


DOI: 10.2174/1568015033357751




Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling

, 3(1): 57 - 65

Jeffrey K. Yao and Ravinder D. Reddy


DOI: 10.2174/1568015033357797




Author Index To Volume 2

, 3(1): 67

Bentham Science Publishers


DOI: 10.2174/1568015033357689




subject Index To Volume 2

, 3(1): 69 - 71

Bentham Science Publishers


DOI: 10.2174/1568015033357706




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science